Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obatoclax and Bortezomib in Relapsed Multiple Myeloma
NCT00719901Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jul 2008
- Primary completion
- Apr 2011
- Countries
- 1
01
Overview
A Phase 2 trial of obatoclax in multiple myeloma (MM), sponsored by National Cancer Institute. Started Jul 2008; status: terminated.
02
Drugs
obatoclax
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00719901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719901.